TCTR20220508002
Active, not recruiting
Not Applicable
Dose Suggestion of Intrathecal Isobaric Bupivacaine for Aging and Overweight Patients
/A0 sites1,000 target enrollmentMay 8, 2022
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- adultspinal anesthesiaagingoverweight
- Sponsor
- /A
- Enrollment
- 1000
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patients undergoing any surgery under spinal anesthesia using isobaric bupivacaine
Exclusion Criteria
- •pregnant woman
- •failed spinal block (no block tested)
- •intrathecal opioids or other adjuvants
- •incomplete records of key data
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Optimal intrathecal hyperbaric bupivacaine dose with opioids for cesarean deliverycesarean deliveryJPRN-UMIN000038098Department of Anesthesiology, Tohoku Kosai Hospital34
Completed
Not Applicable
To find out if the dose of the drug use for spinal anaesthesia can be modify base on height of the patient to achieve pain free surgery.Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperiumCTRI/2021/12/038749Dr Noyomi Saring100
Recruiting
Phase 2
Evaluation of low dose Intrathecal Bupivacaine with dexmedetomidineAnaesthesiaPACTR202403633859291mansoura university90
Active, not recruiting
Phase 1
Isobaric versus hyperbaric intrathecal bupivacaine: influence of specific density on blood pressure change during elective total knee arthroplasty with spinal anesthesiaEUCTR2022-000857-10-BECHU de Liège54
Not yet recruiting
Not Applicable
This study was conducted to use and determine efficacy of isobaric drug levobupivacaine administered via spinal anesthesia in laparoscopic surgeriesCTRI/2024/06/068386Mahatma Gandhi medical college and hospital